Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients

Tundra lists 1 The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT06365541

The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients

Dialysis patients have a higher incidence of cardiovascular events and require more effective measures to delay the progression of heart failure. Many studies have shown that dapagliflozin has cardioprotective effect, but most studies focus on non-dialysis patients with eGFR more than 20ml/min/1.73m2. However, the data on patients with eGFR less than 20ml/min/1.73m2 or dialysis patients, especially peritoneal dialysis patients, is less. Exploring the efficacy and safety of Dapagliflozin in improving heart failure in dialysis patients is of great clinical significance.

Gender: All

Ages: 20 Years - 70 Years

Updated: 2024-04-15

1 state

The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients